vorinostat has been researched along with Cancer of Mediastinum in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwartz, BE | 1 |
| Hofer, MD | 1 |
| Lemieux, ME | 1 |
| Bauer, DE | 1 |
| Cameron, MJ | 1 |
| West, NH | 1 |
| Agoston, ES | 1 |
| Reynoird, N | 1 |
| Khochbin, S | 1 |
| Ince, TA | 1 |
| Christie, A | 1 |
| Janeway, KA | 1 |
| Vargas, SO | 1 |
| Perez-Atayde, AR | 1 |
| Aster, JC | 1 |
| Sallan, SE | 1 |
| Kung, AL | 1 |
| Bradner, JE | 1 |
| French, CA | 1 |
1 other study available for vorinostat and Cancer of Mediastinum
| Article | Year |
|---|---|
Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Topics: Acetylation; Animals; Carcinoma, Squamous Cell; Cell Differentiation; Child; Female; Gene Knockdown | 2011 |